This list is an analysis based on recent market events. It's not an investment recommendation.
About
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
The current price of 6634.TWO is TWD53.50 TWD — it has decreased by -4.12% in the past 24 hours. Watch Sinew Pharma stock price performance more closely on the chart.
What is Sinew Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Sinew Pharma stocks are traded under the ticker 6634.TWO.
Is Sinew Pharma stock price growing?▼
6634.TWO stock has fallen by -3.95% compared to the previous week, the month change is a -16.93% fall, over the last year Sinew Pharma has showed a +24.13% increase.
What is Sinew Pharma market cap?▼
Today Sinew Pharma has the market capitalization of 3.81B
What is Sinew Pharma revenue for the last year?▼
Sinew Pharma revenue for the last year amounts to 47,000 TWD.
What is Sinew Pharma net income for the last year?▼
6634.TWO net income for the last year is -123.75M TWD.
How many employees does Sinew Pharma have?▼
As of November 5, 2026, the company has 52 employees.
In which sector is Sinew Pharma located?▼
Sinew Pharma operates in the Health & Wellness sector.